NSG 5240 ADVANCED PHARMACOLOGY MIDTERM PRACTICE TEST QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 Q&A |STUDY GUIDE|
INSTANT DOWNLOAD PDF
Core Domains
Pharmacokinetics and Pharmacodynamics
Drug Interactions and Adverse Effects
Cardiovascular Pharmacotherapy
Antimicrobial Therapy
Pain Management Pharmacology
Endocrine and Metabolic Pharmacotherapy
Neurological Pharmacotherapy
Regulatory and Legal Compliance in Prescribing
Ethics and Professional Standards
Clinical Decision-Making and Patient Safety
Introduction
,This comprehensive practice exam is designed to assess advanced pharmacology knowledge essential for
nursing practice at the graduate level. The assessment evaluates students' understanding of drug
mechanisms, pharmacokinetic principles, pharmacodynamic responses, and therapeutic applications across
major body systems. The multiple-choice and scenario-based structure emphasizes real-world clinical
application and critical decision-making skills required for safe and effective medication management.
Questions cover foundational theory alongside applied professional knowledge, including regulatory
compliance, ethical considerations, and professional standards. This exam prepares students for clinical
practice by testing their ability to analyze complex patient scenarios, evaluate drug therapy options, and
make informed prescribing decisions that prioritize patient safety and optimize therapeutic outcomes.
Section One: Questions 1–100
Question 1
A 65-year-old patient with chronic kidney disease (CKD) stage 3 is prescribed metformin for type 2 diabetes.
Which pharmacokinetic parameter is most significantly affected by decreased renal function?
A. Drug absorption
B. Drug distribution
C. Drug metabolism
D. Drug excretion
🟢 D. Drug excretion
,🔴 RATIONALE: Metformin is primarily eliminated via renal excretion. In CKD stage 3, decreased glomerular
filtration rate significantly reduces drug excretion, increasing the risk of metformin accumulation and lactic
acidosis. Absorption, distribution, and metabolism are less affected by renal impairment.
Question 2
A nurse practitioner prescribes ibuprofen for a patient with hypertension who is taking lisinopril. What is the
primary concern regarding this drug combination?
A. Increased risk of hypoglycemia
B. Reduced antihypertensive effect and increased renal risk
C. Enhanced sedation effects
D. Increased risk of bleeding
🟢 B. Reduced antihypertensive effect and increased renal risk
🔴 RATIONALE: NSAIDs like ibuprofen can reduce the efficacy of ACE inhibitors (lisinopril) by causing
sodium retention and diminishing vasodilation. Additionally, concurrent use increases the risk of acute kidney
injury, particularly in patients with pre-existing cardiovascular disease.
Question 3
Which of the following best describes the therapeutic index of a drug?
, A. The ratio of the toxic dose to the therapeutic dose
B. The time required for half the drug to be eliminated
C. The maximum effect a drug can produce
D. The concentration needed to occupy 50% of receptors
🟢 A. The ratio of the toxic dose to the therapeutic dose
🔴 RATIONALE: The therapeutic index (TI) is calculated as TD50/ED50, representing the ratio between the
toxic dose and the therapeutic dose. A higher TI indicates a safer drug with a wider margin between effective
and toxic doses.
Question 4
A patient taking warfarin is started on fluconazole for a fungal infection. What monitoring parameter is most
critical?
A. Blood glucose
B. Prothrombin time/INR
C. Serum creatinine
D. Liver transaminases
🟢 B. Prothrombin time/INR
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 Q&A |STUDY GUIDE|
INSTANT DOWNLOAD PDF
Core Domains
Pharmacokinetics and Pharmacodynamics
Drug Interactions and Adverse Effects
Cardiovascular Pharmacotherapy
Antimicrobial Therapy
Pain Management Pharmacology
Endocrine and Metabolic Pharmacotherapy
Neurological Pharmacotherapy
Regulatory and Legal Compliance in Prescribing
Ethics and Professional Standards
Clinical Decision-Making and Patient Safety
Introduction
,This comprehensive practice exam is designed to assess advanced pharmacology knowledge essential for
nursing practice at the graduate level. The assessment evaluates students' understanding of drug
mechanisms, pharmacokinetic principles, pharmacodynamic responses, and therapeutic applications across
major body systems. The multiple-choice and scenario-based structure emphasizes real-world clinical
application and critical decision-making skills required for safe and effective medication management.
Questions cover foundational theory alongside applied professional knowledge, including regulatory
compliance, ethical considerations, and professional standards. This exam prepares students for clinical
practice by testing their ability to analyze complex patient scenarios, evaluate drug therapy options, and
make informed prescribing decisions that prioritize patient safety and optimize therapeutic outcomes.
Section One: Questions 1–100
Question 1
A 65-year-old patient with chronic kidney disease (CKD) stage 3 is prescribed metformin for type 2 diabetes.
Which pharmacokinetic parameter is most significantly affected by decreased renal function?
A. Drug absorption
B. Drug distribution
C. Drug metabolism
D. Drug excretion
🟢 D. Drug excretion
,🔴 RATIONALE: Metformin is primarily eliminated via renal excretion. In CKD stage 3, decreased glomerular
filtration rate significantly reduces drug excretion, increasing the risk of metformin accumulation and lactic
acidosis. Absorption, distribution, and metabolism are less affected by renal impairment.
Question 2
A nurse practitioner prescribes ibuprofen for a patient with hypertension who is taking lisinopril. What is the
primary concern regarding this drug combination?
A. Increased risk of hypoglycemia
B. Reduced antihypertensive effect and increased renal risk
C. Enhanced sedation effects
D. Increased risk of bleeding
🟢 B. Reduced antihypertensive effect and increased renal risk
🔴 RATIONALE: NSAIDs like ibuprofen can reduce the efficacy of ACE inhibitors (lisinopril) by causing
sodium retention and diminishing vasodilation. Additionally, concurrent use increases the risk of acute kidney
injury, particularly in patients with pre-existing cardiovascular disease.
Question 3
Which of the following best describes the therapeutic index of a drug?
, A. The ratio of the toxic dose to the therapeutic dose
B. The time required for half the drug to be eliminated
C. The maximum effect a drug can produce
D. The concentration needed to occupy 50% of receptors
🟢 A. The ratio of the toxic dose to the therapeutic dose
🔴 RATIONALE: The therapeutic index (TI) is calculated as TD50/ED50, representing the ratio between the
toxic dose and the therapeutic dose. A higher TI indicates a safer drug with a wider margin between effective
and toxic doses.
Question 4
A patient taking warfarin is started on fluconazole for a fungal infection. What monitoring parameter is most
critical?
A. Blood glucose
B. Prothrombin time/INR
C. Serum creatinine
D. Liver transaminases
🟢 B. Prothrombin time/INR
